Data / Crowdfunding / Missouri / Pluton Biosciences, Incorporated
Pluton Biosciences, Incorporated: crowdfunding raise on Nvsted, $75,000 to $150,000 (2019)
Pluton Biosciences, Incorporated, a corporation in St. Louis, MO, filed a Form C with the SEC on May 1, 2019 to raise $75,000 to $150,000 in debt through Nvsted. The offering closed on June 7, 2019. In its most recent fiscal year it reported $476,675 in revenue and a net loss of $979,712, with 15 employees.
SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.
- Website
- plutonbio.com
- Funding portal
- Nvsted
- Address
- 11754 Westline Industrial Drive, St. Louis, MO 63146
- Legal form
- Corporation
- Jurisdiction
- MO
- Incorporated
- January 16, 2017
- SEC CIK
- 0001759355
Offering terms
From the amendment filed May 1, 2019.
- Security
- Debt
- Target
- $75,000
- Maximum
- $150,000
- Deadline
- June 7, 2019
- Portal compensation
- 5.0% and $0.00
Financials
From the Form C-AR filed April 30, 2021.
| Most recent fiscal year | Prior fiscal year | Source | |
|---|---|---|---|
| Revenue | $476,675 | $19,431 | sec.gov |
| Cost of goods sold | $188,857 | $6,627 | sec.gov |
| Net income | $-979,712 | $-388 | sec.gov |
| Taxes paid | $0 | $0 | sec.gov |
| Total assets | $709,402 | $557,425 | sec.gov |
| Cash | $191,989 | $14,567 | sec.gov |
| Accounts receivable | $53,280 | $22,785 | sec.gov |
| Short-term debt | $23,514 | $0 | sec.gov |
| Long-term debt | $1,282,531 | $1,168,878 | sec.gov |
Filings
| Filed | Filing | Target | Maximum | Deadline | Note | Source |
|---|---|---|---|---|---|---|
| April 30, 2021 | Annual report | Not listed | Not listed | sec.gov | ||
| June 10, 2019 | Progress update | $75,000 | $150,000 | May 6, 2019 | Pluton Biosciences raised approximately $98,000 during the offering period. Payments are still being processed; the exact amount has yet to be determined. | sec.gov |
| May 1, 2019 | Amendment | $75,000 | $150,000 | June 7, 2019 | This second Amendment is being filed in order to extend the Offering Deadline to June 7, 2019. | sec.gov |
| January 10, 2019 | Amendment | $75,000 | $150,000 | May 6, 2019 | This Amendment is being filed in order to correct the name of the Issuer to "Pluton Biosciences, LLC" instead of "Charlie Walch", the name of the Chief Executive Officer. | sec.gov |
| January 4, 2019 | Offering | $75,000 | $150,000 | May 6, 2019 | sec.gov |
Also on SpecStream
Updated April 30, 2021. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.